Subrata Haldar

4.6k total citations · 2 hit papers
40 papers, 3.9k citations indexed

About

Subrata Haldar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Subrata Haldar has authored 40 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Immunology. Recurrent topics in Subrata Haldar's work include Cell death mechanisms and regulation (17 papers), Immune Cell Function and Interaction (6 papers) and Cancer-related Molecular Pathways (5 papers). Subrata Haldar is often cited by papers focused on Cell death mechanisms and regulation (17 papers), Immune Cell Function and Interaction (6 papers) and Cancer-related Molecular Pathways (5 papers). Subrata Haldar collaborates with scholars based in United States, India and Italy. Subrata Haldar's co-authors include C M Croce, Carlo M. Croce, Nilamani Jena, Aruna Basu, John C. Reed, Maria Monne, Massimo Negrini, Silvia Sabbioni, Suparna Qanungo and William E. Carson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Subrata Haldar

39 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivation of Bcl-2 by phosphorylation.

1995 663 citations Subrata Haldar, Nilamani Jena et al. profile →
Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

1996 569 citations Subrata Haldar, C M Croce et al. PubMed profile →

Peers

Countries citing papers authored by Subrata Haldar

Since Specialization

Citations

This map shows the geographic impact of Subrata Haldar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subrata Haldar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subrata Haldar more than expected).

Fields of papers citing papers by Subrata Haldar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subrata Haldar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subrata Haldar. The network helps show where Subrata Haldar may publish in the future.

Co-authorship network of co-authors of Subrata Haldar

This figure shows the co-authorship network connecting the top 25 collaborators of Subrata Haldar. A scholar is included among the top collaborators of Subrata Haldar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subrata Haldar. Subrata Haldar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polyphenol-rich fraction of Bergenia ligulata regresses colon and breast cancer metastasis by cell-type specific mechanism 2025 ·Phytomedicine ·(unknown), S.C. Roy, Suvranil Ghosh, Subrata Haldar, Kuladip Jana, Subhash C. Mandal, Mahadeb Pal	0
2	Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review 2016 ·Biology of Blood and Marrow Transplantation ·Josephine A. Taverna, Seongseok Yun, (unknown), Ahlam Saleh, Irbaz Bin Riaz, Ivo Abraham, Andrew M. Yeager, Daniel O. Persky, Ali McBride, Subrata Haldar, Faiz Anwer	7
3	Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage. 2011 ·PubMed ·Subrata Haldar, Aruna Basu	6
4	MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer 2011 ·Genes & Cancer ·Alakananda Basu, Hansjüerg Alder, Amer Khiyami, Patrick Leahy, Carlo M. Croce, Subrata Haldar	51
5	Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells 2005 ·Carcinogenesis ·Suparna Qanungo, Madhusudan Das, Subrata Haldar, Aruna Basu	176
6	Restoration of Silenced Peutz-Jeghers Syndrome Gene, LKB1, Induces Apoptosis in Pancreatic Carcinoma Cells 2003 ·Neoplasia ·Suparna Qanungo, Subrata Haldar, Aruna Basu	18
7	Identification of a novel Bcl‐xL phosphorylation site regulating the sensitivity of taxol‐ or 2‐methoxyestradiol‐induced apoptosis 2003 ·FEBS Letters ·Aruna Basu, Subrata Haldar	148
8	2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells 2002 ·Oncogene ·Suparna Qanungo, Aruna Basu, Madhusudan Das, Subrata Haldar	53
9	Increased K+ Efflux and Apoptosis Induced by the Potassium Channel Modulatory Protein KChAP/PIAS3β in Prostate Cancer Cells 2002 ·Journal of Biological Chemistry ·Barbara A. Wible, Liming Wang, Yuri A. Kuryshev, Aruna Basu, Subrata Haldar, Arthur Brown	61
10	Proteasomal Degradation of Human Peptidyl Prolyl Isomerase Pin1-pointing Phospho Bcl2 toward Dephosphorylation 2002 ·Neoplasia ·Aruna Basu, Madhusudan Das, Suparna Qanungo, Xuejun Fan, G C Dubois, Subrata Haldar	36
11	Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1 2001 ·Neoplasia ·Nazima Pathan, Christine Aimé‐Sempé, Shinichi Kitada, (unknown), Subrata Haldar, John C. Reed	57
12	Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1 2001 ·Neoplasia ·Nazima Pathan, Christine Aimé‐Sempé, Shinichi Kitada, Subrata Haldar, John C. Reed	86
13	Regulation of Bcl2 phosphorylation by stress response kinase pathway. 2000 ·International Journal of Oncology ·Alakananda Basu, (unknown), Subrata Haldar	26
14	A potential role for interleukin-15 in the regulation of human natural killer cell survival. 1997 ·Journal of Clinical Investigation ·William E. Carson, Todd A. Fehniger, Subrata Haldar, (unknown), (unknown), (unknown), Carlo M. Croce, Heinz Baumann, Michael A. Caligiuri	363
15	Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. breakdown → 1996 ·PubMed ·Subrata Haldar, (unknown), C M Croce	569
16	Antiapoptosis potential of bcl-2 oncogene by dephosphorylation 1994 ·Biochemistry and Cell Biology ·Subrata Haldar, Nilamani Jena, Carlo M. Croce	40
17	Purification and Characterization of the Bcl-2 Protein 1994 ·Archives of Biochemistry and Biophysics ·Subrata Haldar, Nivedita Jena, (unknown), Shinichi Takayama, John C. Reed, Steven S. Fu, Carlo M. Croce	18
18	Complementation by BCL2 and C-HA-RAS Oncogenes in Malignant Transformation of Rat Embryo Fibroblasts 1990 ·Molecular and Cellular Biology ·John C. Reed, Subrata Haldar, Carlo M. Croce, Michael Cuddy	38
19	Involvement of a specific guanine nucleotide binding protein in receptor immunoglobulin stimulated inositol phospholipid hydrolysis 1989 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·John G. Monroe, Subrata Haldar	20
20	Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferation 1988 ·Clinical Immunology and Immunopathology ·John G. Monroe, Subrata Haldar, Michael B. Prystowsky, Patrick J. Lammie	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact